bioAffinity Technologies, Inc. (BIAF)

NASDAQ

$3.51

$--

(0.00%)

Pre-Market

bioAffinity Technologies, Inc. (BIAF) Live Price Chart

Last updated: ⁦2026-10-20 08:59:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

bioAffinity Technologies, Inc. (BIAF) operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector and is listed on NASDAQ. The stock is currently priced at $3.51, with a market capitalization of $2.24M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.23 to $80.70. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.24M
Open	$3.51
Day's High	$6,997.50
Day's Low	$3.23
Previous Close	$3.51
Volume	169.00
Average Volume	3.77M
P/E Ratio	--
52-Week High	$80.70
52-Week Low	$3.23
Dividend Yield	--
Earnings Date	--

bioAffinity Technologies, Inc. (BIAF) Pre-Market Stock Price

bioAffinity Technologies, Inc. (BIAF) is trading at $3.51 in pre-market trading as of 2026-10-20 08:08:00, unchanged from the previous close of $3.51

Pre-market trading shows how investors are pricing BIAF before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.

bioAffinity Technologies, Inc. (BIAF) 7-Day Stock Price Change

Over the past seven days, bioAffinity Technologies, Inc. (BIAF) moved from $4.73 to $3.51, representing a decline of 25.71% ($1.21).

The stock traded between $3.23 and $5.48 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 344.05 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

BIAF 52-Week Price Position

Position in Range: 0.4%

52W Low$3.23

52W High$80.70

BIAF is currently trading at $3.51, placing it 0.4% of the way from its 52-week low of $3.23 to its 52-week high of $80.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is bioAffinity Technologies, Inc. (BIAF)?

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

bioAffinity Technologies, Inc. Information

Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees	57
Exchange	NASDAQ
Company Website	https://www.bioaffinitytech.com

How to Buy bioAffinity Technologies, Inc. (BIAF) Stock on MEXC

Eligible investors can buy real shares of bioAffinity Technologies, Inc. (BIAF) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BIAF and Place Your Order

Open the RealStocks trading page and search for BIAF. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is bioAffinity Technologies, Inc. (BIAF) stock price today?

bioAffinity Technologies, Inc. (BIAF) is currently trading at $ 3.51, unchanged from the previous close of $ 3.51. Intraday prices update in real time during regular trading hours.

2.Is BIAF stock going up or down today?

As of 2026-10-20 08:08:00, BIAF is trading at $ 3.51, unchanged from its previous close of $ 3.51. The stock has traded between $ 3.23 and $ 6,997.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is BIAF pre-market price?

As of 2026-10-20 08:08:00, BIAF is trading at $ 3.51 in pre-market trading, unchanged from the previous close of $ 3.51. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BIAF after-hours price?

As of 2026-10-20 08:08:00, BIAF is trading at $ 3.51 in after-hours trading, up 0.03% ($0.00) from the regular-session close of $ 3.51. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BIAF stock trading now?

BIAF trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BIAF sit relative to its 52-week high and low?

Over the past 52 weeks, BIAF has traded between a low of $ 3.23 and a high of $ 80.70. At $ 3.51, the stock is positioned 0.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is bioAffinity Technologies, Inc. in?

bioAffinity Technologies, Inc. (BIAF) operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is bioAffinity Technologies, Inc.'s market capitalization and where is it listed?

bioAffinity Technologies, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 2.24M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BIAF valued in terms of P/E ratio and EPS?

BIAF trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -25.28. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does bioAffinity Technologies, Inc. pay a dividend?

bioAffinity Technologies, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.